Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $187.08 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.